DNA vaccines for the treatment of autoimmune disease

Immunology and Cell Biology

Volumn 75, Issue 4, 1997, Pages 409-413

  Ramshaw, Ian A ^a   Fordham, Susan A ^a   Bernard, Claude C A ^c   Maguire, Deborah ^a   Cowden, William B ^a   Willenborg, David O ^b  

^a Biology and Environment   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

Autoimmunity; DNA vaccines; Experimental autoimmune encephalomyelitis

Indexed keywords

DNA VACCINE;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; DRUG THERAPY; GENE TECHNOLOGY; HELPER CELL; NONHUMAN; PREVENTION; REVIEW; VACCINATION;

ANIMALIA;

EID: 0030886496     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.64     Document Type: Review

References (44)

1. Prowie F, Coffman RL. Cytokine regulation of T cell function: potential for therapeutic intervention. Immunol. Today 1993; 14: 270-4.
2. O'Garra A, Murphy K. T-cell subsets in autoimmunity. Curr. Opin. Immunol. 1993; 5: 880-6.
3. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol. Today 1995; 16: 374-9.
4. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 1995; 16: 34-8.
5. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185-8.
6. Ando DG, Clayton J, Kong D, Urban JL, Sercarz EE. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th1 lymphokine subtype. Cell. Immunol. 1989; 124: 132-43.
7. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes. N. Engl. J. Med. 1994; 331: 1428-34.
8. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980; 29: 1-13.
9. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl Acad. Sci. USA 1989; 86: 8000-4.
10. Bergman B, Haskins K. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 1994; 43: 197-203.
11. + islet specific T cell clone. Science 1990; 249: 1433-6.
12. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 1995; 16: 383-6.
13. Rapoport MJ, Jaramillo A, Zipris D et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 1993; 178: 87-99.
14. Pennline K, Roquegaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 1994; 71: 169-75.
15. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 1993; 177: 627-36.
16. Scott B, Liblau R, Degermann S et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994; 1: 1-20.
17. Foulis AK, McGill M, Farquahrson MA. Insulitis in type I (insulin-dependent) diabetes mellitus in man: Macrophages, lymphocytes and interferon-γ-containing cells. J. Pathol. 1991; 165: 97-103.
18. Harrison LC. Islet cell autoantigens in insulin-dependent diabetes: Pandora's box re-visited. Immunol. Today 1992; 13: 348-52.
19. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69-72.
20. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72-5.
21. Miller SD, Karpus WJ. The immunopathogenesis and regulation of T cell-mediated demyelinating diseases. Immunol. Today 1994; 15: 356-8.
22. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. Inflammatory leukocytes and cytokines in peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl Acad. Sci. USA 1992; 89: 574-8.
23. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990; 8: 579-621.
24. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental allergic autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-β, interleukin-4 and prostaglandin E expression in the brain. J. Exp. Med. 1992; 176: 1355-62.
25. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 1992; 149: 2496-505.
26. De Carli M, D'Elios MM, Zancuoghi G, Ramagnani S, Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 1994; 18: 301-8.
27. De Carli M, D'Elios M, Mariotti S et al. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Grave's ophthalmopathy. J. Clin. Endocrinol. Metab. 1993; 77: 1120-4.
28. Romagnani S. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 1994; 12: 227-57.
29. Willenborg DO, Fordham S, Bernard CCA, Cowden WB, Ramshaw IA. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996; 157: 3223-7.
30. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santora JC, Robinson HL. DNA vaccines: Protective immunizations by parental, mucosal, and gene gun inoculations. Proc. Natl Acad. Sci. USA 1993; 90: 11 478-82.
31. Eisenbraun MD, Fuller DH, Haynes JR. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunisation. DNA Cell Biol. 1993; 12: 791-4.
32. Tang D-C, DeVit M, Johnston SA. Genetic immunisation is a simple method for eliciting an immune response. Nature 1992; 356: 152-4.
33. Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 1993; 90: 4156-60.
34. Wolff JA, Malone RW, Williams P et al. Direct transfer into mouse muscle in vivo. Science 1990; 247: 1465-8.
35. Davies HI, Whalen RG, Demeneix BA. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 1993; 4: 151-9.
36. Raz E, Tighe H, Sato Y et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunisation. Proc. Natl Acad. Sci. USA 1996; 93: 5141-5.
37. Sun WH, Burkholder JK, Sun J et al. In vivo cytokine gene transfer by gene gun reduces tumour growth in mice. Proc. Natl Acad. Sci. USA. 1995; 92: 2889-93.
38. Fuller DH, Haynes JR. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glyco-protein 120 vaccine. AIDS Res. Hum. Retroviruses 1994; 10: 1433-41.
39. Leong KH, Ramsay AJ, Ramshaw IA et al. Generation of enhanced immune responses by consecutive immunisation with DNA and recombinant fowl pox vectors. In: Chancock RM, Brown F, Ginsberg HS, Norrby E (eds). Vaccines 1995. New York: Cold Spring Harbor Laboratory Press. 1995; 327-31.
40. Sato Y, Roman M, Tighe H et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunisation. Science 1996; 273: 352-4.
41. Ortiz-Ortiz L, Weigle WO. Cellular events in the induction of experimental allergic encephalomyelitis in rats. J. Exp. Med. 1976; 144: 604-16.
42. Pisetsky DS. The immunologic properties of DNA. J. Immunol. 1996; 156: 421-3.
43. Waisman A, Ruiz PJ, Hischberg DL et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nature Med. 1996; 8: 899-909.
44. Kumar V, Sercaz E. Genetic vaccination: The advantages of going naked. Nature Med. 1996; 8: 857.